Orthopedics This Week

Laminoplasty Cuts Reoperation Risk – but Don’t Put Away the Rods Yet

A 4,412 patient study compared laminoplasty with cervical fusion outcomes. Good study.

The Robot Stayed Late, but the Patient Left Early

This VCU, Duke and Northeastern Ohio team compared robotic assist surgery to “free-hand” surgery in unicompartmental knee surgery. Who won?

The Lead That Couldn’t Take the Stress

The FDA has issued a recall for Boston Scientific’s Infinion CX spine stim leads but only those in inventory, NOT implanted leads.

Why Do Some Patients Choose Spine Surgery – and Others Don’t?

Every surgeon needs to read this study. Back pain is both objective and subjective.

Wandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any Level

Consano Bio Receives FDA Fast Track Designation for C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic Sciatica

Designation follows recent FDA clearance of the Company's IND application for C-1101, an investigational, potentially disease-modifying non-opioid biologic for chronic sciatica.

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

Animal trials show cartilage repair within four weeks following a single injection of chondrocyte spheroids

TailorCare Expands Commercial Reach of Musculoskeletal Care to More than 3 Million Members Nationwide

TailorCare has expanded its clinically led, evidence-based MSK navigation program to more than 200,000 commercial members in Georgia, extending its reach to three of the five national health plans and more than 3 million Americans nationwide.

Alphatec Recalls SafeOp Interfaces Over Intraoperative Monitoring Interruptions

Alphatec Spine voluntarily recalled its SafeOp patient interface due to software issues.

Nanochon Receives Regulatory Approval from Panamá's Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

Nanochon Receives Regulatory Approval from Panamá's Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™